ABUS NASDAQ
Arbutus Biopharma Corporation
1W: +2.1%
1M: +0.2%
3M: +4.0%
YTD: -6.9%
1Y: +38.3%
3Y: +75.5%
5Y: +69.5%
$4.35
-0.09 (-2.03%)
Weekly Expected Move ±4.4%
$4
$4
$4
$4
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$191M
Revenue
+2889.9% YoY
$161M
Net Income
+309.9% YoY
$-34M
Free Cash Flow
+41.8% YoY
100.0%
Gross Margin
94.4%
Op. Margin
94.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE184.8%
ROA142.0%
ROIC-1444.6%
Valuation
P/E5.2
P/B3.2
EV/EBITDA5.1
Leverage
Debt/Equity0.05
Current Ratio15.73
Interest Cov.1817.5x
Quality Scores
Piotroski F5/9
Altman Z17.39
Beneish M95.05